Amy C. Durham

4.8k total citations · 2 hit papers
75 papers, 3.1k citations indexed

About

Amy C. Durham is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Small Animals. According to data from OpenAlex, Amy C. Durham has authored 75 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 17 papers in Small Animals. Recurrent topics in Amy C. Durham's work include Veterinary Oncology Research (38 papers), Infectious Diseases and Mycology (15 papers) and Cancer Cells and Metastasis (7 papers). Amy C. Durham is often cited by papers focused on Veterinary Oncology Research (38 papers), Infectious Diseases and Mycology (15 papers) and Cancer Cells and Metastasis (7 papers). Amy C. Durham collaborates with scholars based in United States, Norway and Slovakia. Amy C. Durham's co-authors include M. Celeste Simon, Ellen Puré, John Scholler, Steven Μ. Albelda, Liang‐Chuan S. Wang, Albert Lo, Carl H. June, Elizabeth L. Buza, Robert H. Vonderheide and Michele M. Hickey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Amy C. Durham

71 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity

2013 515 citations Liang‐Chuan S. Wang, Albert Lo et al. Cancer Immunology Research profile →
Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells

2015 407 citations Albert Lo, Liang‐Chuan S. Wang et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy C. Durham United States	25	1.4k	1.0k	790	789	663	75	3.1k
Susanne I. Wells United States	29	1.3k 0.9×	2.5k 2.4×	382 0.5×	440 0.6×	449 0.7×	82	4.3k
J. Reifenberger Germany	35	1.2k 0.8×	2.8k 2.8×	410 0.5×	418 0.5×	755 1.1×	100	4.7k
Jennifer L. Dembinski Norway	18	2.0k 1.4×	1.9k 1.9×	323 0.4×	561 0.7×	876 1.3×	39	4.6k
Bart Vandekerckhove Belgium	37	1.0k 0.7×	1.8k 1.7×	196 0.2×	2.0k 2.6×	284 0.4×	132	4.4k
Kai Kretzschmar Germany	25	1.5k 1.0×	2.0k 2.0×	283 0.4×	552 0.7×	466 0.7×	58	4.8k
Göran Key Germany	14	970 0.7×	1.4k 1.4×	502 0.6×	335 0.4×	472 0.7×	19	3.5k
Ilene D. Kurzman United States	37	556 0.4×	760 0.8×	2.3k 2.9×	643 0.8×	148 0.2×	79	3.8k
Paul Zajac Switzerland	27	1.1k 0.8×	654 0.6×	169 0.2×	1.1k 1.5×	212 0.3×	57	2.4k
Hiroshi Shinkai Japan	37	686 0.5×	1.1k 1.1×	460 0.6×	839 1.1×	361 0.5×	153	4.1k
Daniela Mihic‐Probst Switzerland	28	1.1k 0.7×	1.1k 1.0×	237 0.3×	472 0.6×	275 0.4×	63	2.4k

Countries citing papers authored by Amy C. Durham

Since Specialization

Citations

This map shows the geographic impact of Amy C. Durham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy C. Durham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy C. Durham more than expected).

Fields of papers citing papers by Amy C. Durham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy C. Durham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy C. Durham. The network helps show where Amy C. Durham may publish in the future.

Co-authorship network of co-authors of Amy C. Durham

This figure shows the co-authorship network connecting the top 25 collaborators of Amy C. Durham. A scholar is included among the top collaborators of Amy C. Durham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy C. Durham. Amy C. Durham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Xiaowei, John N. Lukens, Tillman Pearce, et al.. (2025). Preliminary evaluation of the safety and feasibility of toll-like receptor ligand CB101 combined with hypofractionated radiation therapy in canine head and neck cancer: a pilot study. PubMed. 2(1). 18–18.

Pircher, Andreas, Michael A. W. Eaton, Atsushi Hata, et al.. (2024). 117O Stereotactic body radiotherapy (SBRT) with pembrolizumab (pembro) for unresected stage I/II non-small cell lung cancer (NSCLC): The randomized, double-blind, phase III KEYNOTE-867 study. Immuno-Oncology Technology. 24. 100746–100746. 3 indexed citations

Dufour, Valérie, et al.. (2024). Clinical descriptive and long‐term outcome of melanocytic uveal lesions in young dogs: 40 cases (45 eyes) including 13 cases of sector iridectomy. Veterinary Ophthalmology. 28(2). 371–385. 1 indexed citations

Lenz, Jennifer, Charles‐Antoine Assenmacher, Nicholas S. Keuler, et al.. (2021). Increased tumor-infiltrating lymphocyte density is associated with favorable outcomes in a comparative study of canine histiocytic sarcoma. Cancer Immunology Immunotherapy. 71(4). 807–818. 12 indexed citations

Terajima, Masahiko, Yuki Taga, Becky K. Brisson, et al.. (2021). Collagen molecular phenotypic switch between non-neoplastic and neoplastic canine mammary tissues. Scientific Reports. 11(1). 8659–8659. 8 indexed citations

Graim, Kiley, David G. Robinson, Nicholas Carriero, et al.. (2020). Modeling molecular development of breast cancer in canine mammary tumors. Genome Research. 31(2). 337–347. 12 indexed citations

Durham, Amy C., et al.. (2019). Outcomes in 40 cats with discrete intermediate‐ or large‐cell gastrointestinal lymphoma masses treated with surgical mass resection (2005‐2015). Veterinary Surgery. 48(7). 1218–1228. 11 indexed citations

Durham, Amy C., et al.. (2019). Ability of ultrasonography to predict the presence and location of histologic lesions in the small intestine of cats. Journal of Veterinary Internal Medicine. 33(3). 1278–1285. 13 indexed citations

Zhao, Liang, Chelsea Thorsheim, Timothy J. Stalker, et al.. (2017). Phosphatidylinositol transfer protein-α in platelets is inconsequential for thrombosis yet is utilized for tumor metastasis. Nature Communications. 8(1). 1216–1216. 26 indexed citations

10.

Lee, Kyoung Eun, Michelle Spata, Lauren J. Bayne, et al.. (2015). Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia. Cancer Discovery. 6(3). 256–269. 179 indexed citations

11.

Glass, Eric N., et al.. (2015). Clinical, Magnetic Resonance Imaging, and Histopathologic Findings in 6 Dogs with Surgically resected Extraparenchymal Spinal Cord Hematomas. Journal of Veterinary Internal Medicine. 29(1). 225–230. 11 indexed citations

12.

Shay, Jessica E.S., Hongxia Z. Imtiyaz, Sharanya Sivanand, et al.. (2014). Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancer. Carcinogenesis. 35(5). 1067–1077. 57 indexed citations

13.

Watson, Victoria E., et al.. (2013). Focal Intestinal Lipogranulomatous Lymphangitis in 6 Dogs (2008–2011). Journal of Veterinary Internal Medicine. 28(1). 48–51. 14 indexed citations

14.

Wang, Liang‐Chuan S., Albert Lo, John Scholler, et al.. (2013). Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity. Cancer Immunology Research. 2(2). 154–166. 515 indexed citations breakdown →

15.

Wileyto, E. Paul, Joann M. Miller, Min Yuan, et al.. (2012). Tumor Vascular Microenvironment Determines Responsiveness to Photodynamic Therapy. Cancer Research. 72(8). 2079–2088. 88 indexed citations

16.

Avila, Jacqueline L., Scott Troutman, Amy C. Durham, & Joseph L. Kissil. (2012). Notch1 Is Not Required for Acinar-to-Ductal Metaplasia in a Model of Kras-Induced Pancreatic Ductal Adenocarcinoma. PLoS ONE. 7(12). e52133–e52133. 19 indexed citations

17.

Durham, Amy C., Kathleen M. Stewart, Ashley Goss, et al.. (2011). Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium. Journal of Clinical Investigation. 121(5). 1935–1945. 133 indexed citations

18.

Gilad, Oren, Barzin Y. Nabet, Ryan L. Ragland, et al.. (2010). Combining ATR Suppression with Oncogenic Ras Synergistically Increases Genomic Instability, Causing Synthetic Lethality or Tumorigenesis in a Dosage-Dependent Manner. Cancer Research. 70(23). 9693–9702. 173 indexed citations

19.

Bertout, Jessica A., Shetal Patel, Benjamin H. Fryer, et al.. (2009). Heterozygosity for Hypoxia Inducible Factor 1α Decreases the Incidence of Thymic Lymphomas in a p53 Mutant Mouse Model. Cancer Research. 69(7). 3213–3220. 28 indexed citations

20.

McNeill, Conor J., Karin U. Sørenmo, Frances S. Shofer, et al.. (2009). Evaluation of Adjuvant Doxorubicin-Based Chemotherapy for the Treatment of Feline Mammary Carcinoma. Journal of Veterinary Internal Medicine. 23(1). 123–129. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact